Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Mitogen-activated protein kinase pathway in osteosarcoma.

Na KY, Kim YW, Park YK.

Pathology. 2012 Oct;44(6):540-6.

PMID:
22935974
2.

Expression and prognostic role of pan-Ras, Raf-1, pMEK1 and pERK1/2 in patients with hepatocellular carcinoma.

Chen L, Shi Y, Jiang CY, Wei LX, Wang YL, Dai GH.

Eur J Surg Oncol. 2011 Jun;37(6):513-20. doi: 10.1016/j.ejso.2011.01.023.

PMID:
21324414
3.

Thrombin-stimulated cell proliferation mediated through activation of Ras/Raf/MEK/MAPK pathway in canine cultured tracheal smooth muscle cells.

Lin CC, Shyr MH, Chien CS, Wang CC, Chiu CT, Hsiao LD, Yang CM.

Cell Signal. 2002 Mar;14(3):265-75.

PMID:
11812655
4.

miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.

Chen L, Wang Q, Wang GD, Wang HS, Huang Y, Liu XM, Cai XH.

FEBS Lett. 2013 May 2;587(9):1366-72. doi: 10.1016/j.febslet.2013.03.007.

6.

Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma.

Abdeen A, Chou AJ, Healey JH, Khanna C, Osborne TS, Hewitt SM, Kim M, Wang D, Moody K, Gorlick R.

Cancer. 2009 Nov 15;115(22):5243-50. doi: 10.1002/cncr.24562.

7.

Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.

Marzec M, Kasprzycka M, Liu X, Raghunath PN, Wlodarski P, Wasik MA.

Oncogene. 2007 Feb 8;26(6):813-21.

PMID:
16909118
8.

Bradykinin B2 receptor-mediated proliferation via activation of the Ras/Raf/MEK/MAPK pathway in rat vascular smooth muscle cells.

Yang CM, Chien CS, Ma YH, Hsiao LD, Lin CH, Wu C.

J Biomed Sci. 2003 Mar-Apr;10(2):208-18.

PMID:
12595757
10.

Untying the regulation of the Raf-1 kinase.

Dhillon AS, Kolch W.

Arch Biochem Biophys. 2002 Aug 1;404(1):3-9. Review.

PMID:
12127063
11.
12.
13.

[Expressions of Raf-1 kinase, phosphorylated mitogen extracellular kinase 1, and phosphorylated extracellular signal-regulated protein kinase 1/2 in hepatocellular carcinoma and their relationship with prognosis].

Chen L, Shi Y, Jiang CY, Sun Q, Dai GH.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Aug;32(4):424-8. doi: 10.3881/j.issn.1000-503X.2010.04.014. Chinese.

PMID:
20868603
14.

Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients.

McGlynn LM, Kirkegaard T, Edwards J, Tovey S, Cameron D, Twelves C, Bartlett JM, Cooke TG.

Clin Cancer Res. 2009 Feb 15;15(4):1487-95. doi: 10.1158/1078-0432.CCR-07-4967.

15.

Sphingomyelinase decreases type II collagen expression in bovine articular cartilage chondrocytes via the ERK signaling pathway.

Gilbert SJ, Blain EJ, Duance VC, Mason DJ.

Arthritis Rheum. 2008 Jan;58(1):209-20. doi: 10.1002/art.23172.

16.

Activation of B-Raf and regulation of the mitogen-activated protein kinase pathway by the G(o) alpha chain.

Antonelli V, Bernasconi F, Wong YH, Vallar L.

Mol Biol Cell. 2000 Apr;11(4):1129-42.

18.

[Gene profiling of MAPK pathway in human osteosarcoma].

Li GD, Cai ZD, Zhang YQ, Gong HY, Tang H, Zhang QL.

Zhonghua Zhong Liu Za Zhi. 2009 May;31(5):340-5. Chinese.

PMID:
19799081
20.

Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.

Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C.

Cancer Res. 2002 Nov 1;62(21):6039-44.

Items per page

Supplemental Content

Support Center